Bio-Rad Labs (BIO) Tops Q3 EPS by $1.27
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $380.12 -1.55%
Revenue Growth %: -0.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -0.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $3.71, $1.27 better than the analyst estimate of $2.44. Revenue for the quarter came in at $715.2 million versus the consensus estimate of $661.87 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- GameStop beats second quarter estimates on collectibles
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
